Endocarditis Quiz

Endocarditis: Core Concepts and Clinical Pearls

Infective endocarditis (IE) is an infection of the endocardial surface of the heart, most commonly involving the heart valves. It can also involve intracardiac devices. This condition carries significant morbidity and mortality, making rapid diagnosis and appropriate management critical for patient outcomes.

Pathophysiology and Risk Factors

The development of IE typically requires two main factors: endothelial damage and bacteremia. Damaged endothelium, often from turbulent blood flow (e.g., in congenital heart disease, prosthetic valves, or rheumatic heart disease), provides a nidus for platelet and fibrin deposition, forming a sterile vegetation. Subsequent bacteremia, from sources like dental procedures, IV drug use, or indwelling catheters, allows microorganisms to adhere to and colonize this nonbacterial thrombotic endocarditis (NBTE), leading to an infected vegetation.

• High-Risk Conditions: Prosthetic heart valves, previous endocarditis, certain complex congenital heart diseases, and acquired valvular dysfunction.
• Common Sources of Bacteremia: Dental manipulations, intravenous drug use, surgical procedures, and nosocomial infections.

The Modified Duke Criteria for Diagnosis

Diagnosing IE is based on a combination of clinical, microbiological, and imaging findings, formalized in the Modified Duke Criteria. A definitive diagnosis requires meeting 2 major criteria, 1 major and 3 minor criteria, or 5 minor criteria.

Common Causative Organisms

The microbiology of endocarditis varies depending on the clinical context (e.g., native vs. prosthetic valve, IV drug use).

• Staphylococcus aureus: The most common cause overall, especially in healthcare-associated IE and among people who inject drugs. It is highly virulent and associated with rapid valve destruction.
• Viridans group streptococci: Often associated with subacute presentations and typically originate from the oral cavity.
• Enterococci: Commonly seen in older men after genitourinary procedures and in nosocomial settings.
• Streptococcus gallolyticus (formerly S. bovis): Strongly associated with colorectal cancer and other gastrointestinal pathologies.
• HACEK group: A group of fastidious gram-negative organisms (Haemophilus, Aggregatibacter, Cardiobacterium, Eikenella, Kingella) known for causing large vegetations.

Clinical Manifestations

Symptoms can be acute and fulminant or subacute and indolent. Classic signs include fever, a new or changing heart murmur, and embolic phenomena. Peripheral stigmata, while classic, are less common with modern diagnosis and treatment.

Management and Prophylaxis

Treatment involves prolonged courses of parenteral antibiotics, often for 4-6 weeks. The choice of antibiotic depends on the causative organism and its sensitivities. Surgical intervention may be required for complications like heart failure, uncontrolled infection, or prevention of embolism from large vegetations.

Frequently Asked Questions (FAQ)

This content is for educational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified health provider with any questions you may have regarding a medical condition.